CytomX is developing the next generation of highly targeted antibody therapeutics.
Read More

Recent News


CytomX Therapeutics to Present Data from Anti-Jagged Probody Program at Upcoming AACR Annual Meeting 2014

More Events >

Upcoming Events


Allicense 2014 – The Next Generation of Dealmaking in San Francisco

More Events >

6.2.14 - 6.5.14

Jefferies 2014 Global Healthcare Conference, New York City

More Events >